NASDAQ:BKYI - BIO-key International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.12 +0.04 (+3.70 %) (As of 05/22/2019 07:42 AM ET)Previous Close$1.0762Today's Range$1.08 - $1.1252-Week Range$0.75 - $3.64Volume10,002 shsAverage Volume24,176 shsMarket Capitalization$15.77 millionP/E RatioN/ADividend YieldN/ABeta2.11 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. The company's products include Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many and one-to-one user identification; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. Its products also comprise ID Director, a solution for single sign on integration with CA Technologies SiteMinder, Oracle's Fusion Middleware SSO, IBM Tivoli Access Manager, and other solutions; and WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in insecure environments, such as the world wide Web or off-site cloud environments. The company also sells third-party hardware components. BIO-key International, Inc. markets its products through its direct sales force, as well as through distributors, resellers, integrators, and partner networks to government and corporate customers primarily in North America. It has strategic partnership with Quantum Business Advisory to bring its software and hardware solutions to enterprises in India. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Receive BKYI News and Ratings via Email Sign-up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer & office equipment Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:BKYI Previous Symbol CUSIPN/A CIK1019034 Webhttp://www.bio-key.com/ Phone732-359-1100Debt Debt-to-Equity Ratio0.05 Current Ratio2.15 Quick Ratio2.63Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.05 million Price / Sales3.89 Cash FlowN/A Price / Cash FlowN/A Book Value$0.65 per share Price / Book1.72Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-6,870,000.00 Net Margins-172.60% Return on Equity-60.41% Return on Assets-53.38%Miscellaneous Employees18 Outstanding Shares14,082,000Market Cap$15.77 million Next Earnings Date8/13/2019 (Estimated) OptionableNot Optionable BIO-key International (NASDAQ:BKYI) Frequently Asked Questions What is BIO-key International's stock symbol? BIO-key International trades on the NASDAQ under the ticker symbol "BKYI." How were BIO-key International's earnings last quarter? BIO-key International, Inc. (NASDAQ:BKYI) released its quarterly earnings data on Wednesday, May, 15th. The technology company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.04) by $0.09. The technology company had revenue of $0.55 million for the quarter. BIO-key International had a negative net margin of 172.60% and a negative return on equity of 60.41%. View BIO-key International's Earnings History. When is BIO-key International's next earnings date? BIO-key International is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for BIO-key International. What price target have analysts set for BKYI? 1 Wall Street analysts have issued 12-month price targets for BIO-key International's shares. Their predictions range from $4.00 to $4.00. On average, they expect BIO-key International's share price to reach $4.00 in the next year. This suggests a possible upside of 257.1% from the stock's current price. View Analyst Price Targets for BIO-key International. What is the consensus analysts' recommendation for BIO-key International? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIO-key International in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BIO-key International. Has BIO-key International been receiving favorable news coverage? Press coverage about BKYI stock has trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. BIO-key International earned a news sentiment score of 1.5 on InfoTrie's scale. They also assigned press coverage about the technology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. Who are some of BIO-key International's key competitors? Some companies that are related to BIO-key International include Intrusion (INTZ), Black Box (BBOX), BOS Better OnLine Sol (BOSC), eRoomSystem Technologies (ERMS), COPsync (COYNQ), Echelon (ELON), Interphase (INPHQ), NEC (NIPNF) and Xplore Technologies (XPLR). What other stocks do shareholders of BIO-key International own? Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include InterDigital Wireless (IDCC), Organovo (ONVO), Athersys (ATHX), Corbus Pharmaceuticals (CRBP), Energy Recovery (ERII), Ampliphi Biosciences (APHB), Palatin Technologies (PTN), Arbutus Biopharma (ABUS), Aclaris Therapeutics (ACRS) and AcelRx Pharmaceuticals (ACRX). Who are BIO-key International's key executives? BIO-key International's management team includes the folowing people: Mr. Michael W. DePasquale, Chairman & CEO (Age 64)Ms. Cecilia C. Welch, Chief Financial Officer (Age 59)Ms. Mira K. LaCous, Chief Technology Officer (Age 57)Mr. Scott Mahnken, VP of Marketing (Age 59)Mr. James Sullivan, Sr. VP of Strategy & Bus. Devel. (Age 52) How do I buy shares of BIO-key International? Shares of BKYI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is BIO-key International's stock price today? One share of BKYI stock can currently be purchased for approximately $1.12. How big of a company is BIO-key International? BIO-key International has a market capitalization of $15.77 million and generates $4.05 million in revenue each year. BIO-key International employs 18 workers across the globe. What is BIO-key International's official website? The official website for BIO-key International is http://www.bio-key.com/. How can I contact BIO-key International? BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company can be reached via phone at 732-359-1100 or via email at [email protected] MarketBeat Community Rating for BIO-key International (NASDAQ BKYI)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 118 (Vote Outperform)Underperform Votes: 121 (Vote Underperform)Total Votes: 239MarketBeat's community ratings are surveys of what our community members think about BIO-key International and other stocks. Vote "Outperform" if you believe BKYI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BKYI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: What is the Quick Ratio? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.